Rapid Hair Cell Loss: A Mouse Model for Cochlear Lesions
- First Online:
- Cite this article as:
- Taylor, R.R., Nevill, G. & Forge, A. JARO (2008) 9: 44. doi:10.1007/s10162-007-0105-8
- 672 Views
In comparison to other mammals, mice have proved extremely resistant to aminoglycoside-induced hair cell ablation in vivo. In this paper we examine the pattern and extent of cochlear lesions rapidly induced with a combination of a single dose of aminoglycoside (kanamycin) followed by a loop diuretic (bumetanide). With this protocol, the vestibular system was unaffected, but in the cochlea, there was extensive loss of outer hair cells (OHC) that commenced in the basal coil and progressed apically so that, by 48 h, OHC loss was almost complete. TUNEL-positive nuclei and activated caspase-3 labeling demonstrated that most OHC died via a classical apoptotic pathway. However, scattered debris within the OHC region suggested that many apoptotic cells ruptured prior to completion of apoptosis. Following lesion repair, supporting cells retained characteristics of differentiated cells but positional shift occurred. In comparison to OHC loss, inner hair cell (IHC) death was delayed and only observed in 50% of all cochleae examined even after extensive reorganization of the tissue. The coadmininstration of diuretic with FM1-43, used as a tracer for aminoglycoside uptake, indicated entry into IHC as readily as OHC, suggesting that the differential response to aminoglycoside was not due to differential uptake. Where IHC death was ongoing, there were indications of different modes of cell death: cells with morphological features of autophagy, necrosis, and apoptosis were apparent. In addition to damage to the organ of Corti, there was a significant and progressive decrease in strial thickness beginning as early as 7 days posttreatment. This was due predominantly to degeneration of marginal cells. The strial pathology resembled that reported after noise damage and with aging. This in vivo protocol provides a robust model in which to obtain extensive OHC loss in the mature cochleae of mice and is a means with which to examine different aspects of cochlear pathology in transgenic or mutant strains.
Keywordsaminoglycosidediuretichair cell deathautophagystria vascularisFM1-43
The ability to manipulate the genome, and the existence of many naturally occurring mutants with auditory phenotypes that have corollaries in humans, has made the mouse the animal of choice for a variety of studies of the auditory system. Mice are thus of potential value in investigation of the molecular basis of cochlear pathologies and of the possibilities for therapeutic interventions aimed at preventing deafness or at regenerating hair cells as a means to restore hearing. Such investigations require models of cochlear injury and of induced hair cell loss with which to explore the underlying basic mechanisms. The ototoxic action of aminoglycosides, in addition to its clinical significance as a major causative factor in the incidence of acquired hearing loss and balance dysfunction throughout the world, also provides a more general model of mechanisms of injury to the cochlea. In particular, the basis of hair cell death, and of how the cochlea responds to such damage, can be explored (Forge and Schacht 2000). However, it has proved remarkably difficult to induce hair cell loss in vivo in the mature cochleae of mice as easily as can be achieved in other animal models such as guinea pigs. It seems that very high doses of aminoglycoside need to be administered to mice before any ototoxicity is evident (Wu et al. 2001). With many aminoglycosides, including gentamicin, the aminoglycoside most commonly used in experimental studies of ototoxicity, and neomycin, the dosing conditions sufficient to induce hair cell loss in mice could not be determined. At lower doses given repeatedly on successive days, no hair cell loss occurred, but with higher doses, single injections of the drug were rapidly lethal. However, it proved possible to administer high doses of kanamycin. Using twice daily injections of this high dose for 14 days, progressive hair cell loss occurred (Wu et al. 2001). While this regime has certain advantages, the need for so many repeated injections makes this procedure somewhat difficult to employ, especially with large numbers of animals. A combination of a single dose of aminoglycoside closely followed by a single dose of a loop diuretic is known to cause very rapid hair cell loss in humans and experimental animals (West et al. 1973; Russell et al. 1979; Brummett et al. 1981; Webster and Webster 1981). It is a combination recently used in guinea pigs to induce hair cell loss prior to testing a means to induce hair cell regeneration (Izumikawa et al. 2005). Prieve and Yanz (1984) found that kanamycin in combination with bumetanide rapidly induced marked permanent high-frequency threshold shifts in mice. We therefore examined in detail the effects of this combination, using the high doses of kanamycin identified by Wu et al. (2001), upon the cochlea in mice.
METHODS AND MATERIALS
CBA/Ca mice, 18–21 days old, weighing 7–10 g were used. Animals received a single subcutaneous injection of kanamycin (Sigma, St. Louis, MO, USA) dissolved in phosphate-buffered saline (PBS), at 1 mg/g body weight, followed 40 min later by a single intraperitoneal injection of a clinical preparation of the loop diuretic, bumetanide (Burinex, injection, Leo) at 0.05 mg/g. Generally, inner ear tissues were obtained for examination at 24 and 48 h and at 1, 2, and 4 weeks after injections. Some cochleae were obtained at 6 and 18 h after treatment to examine the onset of any effects and others at 8, 12, and 14 weeks posttreatment to explore the longer-term consequences. From any one group of animals injected on the same occasion, treated animals were taken at different time points, usually two animals from each group at each time point. The two ears from any individual animal were prepared for examination by different methods. In total, 156 animals were used. To test for the generality of effects of kanamycin, the use of amikacin at up to 1 mg/g body weight and of gentamicin were examined. The cochleae of these animals were isolated at 7 or 14 days posttreatment. The cochleae of two untreated “aged” CBA/Ca animals, one 12 months old and one 24 months old, were also included in the study. All animal work conformed to the regulated procedures of the British Home Office.
Following its isolation, openings into the cochlea were made by removing a piece of bone covering the apex, rupturing the round window membrane, extracting the stapes from the oval window, and breaking the bone between round and oval windows to give access to the basal cochlear turn and the vestibule. Fixative was perfused directly into the cochlea through these openings. In preparation for immunohistochemistry and fluorescence microscopy of whole mounts and cryosections, tissue was fixed in 4% paraformaldehyde in PBS for 60 min. For electron microscopy, tissue was fixed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer with 3 mM CaCl2 for 2 h at room temperature. Following fixation, cochleae were decalcified in 4.13% EDTA pH 7.3 for 24–48 h at 4°C. Organs of Corti were carefully dissected from the cochleae for whole mount immunohistochemistry and scanning electron microscopy (SEM). Decalcified cochleae were processed and embedded intact prior to thin sectioning for transmission electron microscopy (TEM) or cryosectioning.
Whole mounts were rinsed in PBS and permeabilized for 30 min in 0.2% Triton X-100. To identify the pattern and extent of any hair cell loss and concurrent nuclear morphology, the tissue was then incubated in 2 μg/ml phalloidin-flourescein isothiocyanate (FITC), 2 μg/ml propidium iodide, and 100 μg/ml DNAse-free RNase at 37°C for 40 min, or with 2 μg/ml phalloidin conjugated to either FITC or tetramethyl rhodamine iso-thiocyanate alone for 1 h, and nuclei were counterstained with 4′,6-diamidino-2-phenylindole (DAPI). For immunohistochemical labeling, after permeabilization, tissue was incubated at room temperature for 40–60 min in a blocking solution consisting of 5% horse serum and 0.5% bovine serum albumen in PBS with 0.2% Triton X-100. Specimens were washed and incubated overnight at 4°C in primary antibody diluted in PBS with 100 mM lysine and 0.2% Triton X-100. Following several washes, tissue was incubated in appropriate secondary antibodies together with fluorophore-conjugated phalloidin (Sigma). Polyclonal antibody to calretinin (Chemicon, Billerica, MA, USA, 1:200) or monoclonal antibody to parvalbumin (Sigma, 1:200) were used to visualize hair cells in conjunction with phalloidin conjugated to a fluorophore. Polyclonal antibody to rat prestin [gift from JF Ashmore (Weber et al. 2002)] was used to identify outer hair cell (OHC) plasma membranes in some experiments. To identify possible activation of caspase-3 during cell death, tissue was incubated with polyclonal antibody to activated caspase-3 (1:100, Cell Signaling Technology, Danvers, MA, USA). DNA fragmentation, an indicator of apoptosis, was examined by the TUNEL technique using an Apoptag kit with fluorescent (FITC)-conjugated antidigoxigenin antibodies (Chemicon). In negative controls for antibody labeling, the primary antibody was omitted and undamaged tissue was processed in parallel with damaged tissue in examinations of activated caspase-3 and TUNEL. Samples were mounted in Vectashield containing DAPI (Vector, Burlingame, CA, USA) to counterstain nuclei. The whole mount samples were examined and imaged using either wide-field epifluorescence microscopy on a Zeiss Axioplan with images recorded digitally using a Zeiss Axiocam, or by confocal microscopy on a Zeiss Meta confocal laser scanning microscope. Digital images were exported as TIFF files and adjusted for optimal contrast and brightness.
Preparation for electron microscopy
After the initial fixation in glutaraldehyde, tissue was postfixed in 1% OsO4 in 0.1 M cacodylate buffer for 90 min. SEM samples were then processed by the thiocarbohydrazide-OsO4 repeated protocol (Davies and Forge 1987) prior to dehydration through an alcohol series and critical point drying. Samples were sputter coated with gold–palladium or platinum. SEM images were collected digitally. In preparation for thin sectioning, intact, decalcified cochleae were partially dehydrated to 70% ethanol and then incubated in saturated uranyl acetate in 70% ethanol overnight before completing dehydration and embedding in plastic. Sections approximately parallel to the modiolus that included the whole height of the cochlea were taken at five to six successive levels to enable all turns of the cochlear spiral to be examined through the entire depth of the cochlea. At each level, an initial 1-μm-thick section was stained in toluidine blue and examined by light microscopy. A series of thin sections were then cut, at least two of which were collected on formvar-coated single-slot grids to gain uninterrupted views of the section from base to apex. This procedure enabled examination of the entire cochlea, base to apex, and across its whole width, and of the lateral walls and the organ of Corti at the same locations. Thin sections were counterstained in uranyl acetate and lead citrate. Transmission electron micrographs were collected digitally using a Gatan camera. All digital images were formatted with Photoshop v6 (Adobe Systems, San Jose, CA, USA).
Assessment of stria vascularis
Measurements of the thickness of the stria vascularis (SV) were taken from thin sections. At each cochlear turn in each section at each level in each cochlea, three images containing the entire thickness of the SV (endolymphatic surface to interface with spiral ligament) were taken from the central portion of the strial width (along the axis of Reissner’s membrane to spiral prominence). Using the Gatan analysis software, measurements of the thickness of the SV, from the endolymphatic surface of marginal cells to the spiral ligament side of basal cells, were obtained from each image. For each cochlea examined, data were pooled to obtain a mean for both basal and apical turns of the cochlea. Measurements of strial thickness were statistically analyzed using Graphpad InStat. One-way ANOVA with Tukey correction was performed.
FM1-43 uptake into hair cells
The uptake of FM1-43 into hair cells in the mature organ of Corti was used to test for possible differences in uptake of drugs into different cell types. For in vitro studies, auditory bullae were isolated from mice aged P18–P21 and the cochlea exposed. Rapidly, and without immersion of the bulla in fluid, the bone covering the apical end of the cochlea and bone between the round and oval windows at the base were removed to provide openings into the cochlea. The bulla with the now opened cochlea was then dropped into 3 μM FM1-43 in 4-2-hydroxyethyl-1-piperazineethanesulfonic acid-buffered Hanks balanced salt solution (Hb-HBSS) that had been equilibrated at 37°C. The cochlea was incubated at 37°C for 10 s before immediate transfer to ice-cold Hb-HBSS, followed by three further washes in Hb-HBSS. Strips of organ of Corti were then isolated, mounted on slides, and immediately examined as whole mounts by wide-field epifluorescence microscopy. Three replicates of this experiment were performed on each of two occasions.
To assess FM1-43 uptake in vivo, mice were injected subcutaneously with 4 μg/g FM1-43 (Meyers et al. 2003) dissolved in PBS. Some animals then received 0.05 mg/g bumetanide by intraperitoneal injection 40 min later. Other animals did not; they received no further treatment. Inner ear tissues were dissected at 2, 6, and 24 h following injection and immediately examined as whole-mount preparations by epifluorescence microscopy. The cochleae from at least three animals at each time point under each condition were examined. Imaging and image recording were performed using the same settings on the microscope and camera system for comparison between animals that had received bumetanide and FM1-43 and those that received only FM1-43. Tissue from animals that received kanamycin rather than FM1-43 with bumetanide acted as controls.
This study was designed to examine the pattern and extent of cochlear lesions induced with a combination of a single dose of aminoglycoside, kanamycin followed by the loop diuretic, bumetanide. Mice that received a single injection of kanamycin at a dose of 1 mg/g showed no long-lasting systemic effects. Exceeding this dose, however, proved to be toxic, resulting in paralysis, altered breathing patterns, and subsequent death within 20 min (all six animals given 1.25 mg/g died). Following administration of 1 mg/g kanamycin alone, omitting the loop diuretic, no damage to the inner ear was evident at any time point examined; 24 h (n = 3), 48 h (n = 2), 7 days (n = 2), and 14 days (n = 2). Likewise, animals that received only the bumetanide showed no adverse effects or cochlear abnormalities at the time points examined [24 h (n = 2); 48 h n = 1; 7 days n = 2]. In contrast, animals that received the combination of kanamycin followed by bumetanide showed an acute response as early as 18 h subsequent to the treatment.
In the cochlea, the kanamycin–bumetanide protocol resulted in virtually complete loss of OHC by 48 h postinjection (effects described in detail below). Phalloidin and DAPI staining of whole mount preparations, SEM, and thin sections revealed that the protocol was effective in 80% of injected mice (194 cochleae out of the 244 examined by these methods). In the remaining 20% of injected animals, no hair cell loss was evident. The cochleae of these animals appeared essentially unaffected. In some animals, during the initial subcutaneous injection of kanamycin, there was leakage of fluid from the injection site, and in others the injected bolus persisted for some time under the skin. It is likely that these animals received a lower systemic dose or there was slow uptake of the drug and this may account for the absence of damage in a proportion of injected animals. However, the animals in which this potentially inadequate dosing occurred were not systematically recorded, particularly in the earlier stages of the study, so whether the animals in which this happened were the only ones to show no effect after treatment is uncertain.
There was no obvious effect on the vestibular system. There was no evidence of hair loss in either utricular maculae or cristae, and no abnormal behavior was observed in any of the experimental mice in which loss of cochlear hair cells had occurred.
Effects on the organ of Corti
Pattern and extent of OHC loss
Apoptotic cells can be detected by terminal deoxynucleotidyl transferase (TdT)-mediated 2′-deoxyuridine 5′-triphosphate nick end labeling (TUNEL) in which the free 3′-OH termini of fragmented DNA are labeled with modified nucleotides. TUNEL-positive nuclei were located in the region of OHC loss at both 24 h posttreatment and 48 h (Fig. 2B). In all TUNEL-positive cells, the nuclei were pyknotic, with condensed chromatin. There were no TUNEL-positive nuclei in undamaged control tissue (not shown). To clarify whether hair cells died via a classical apoptotic pathway, immunohistochemistry was performed using an antibody to detect activated caspase-3, an effector of the caspase-dependent apoptotic pathway. This revealed cells positive for activated caspase-3 within the transitional zone (Fig. 2C). The nuclei of these cells were typical of apoptotic cells: pyknotic, with marginated or condensed chromatin. Phalloidin labeling revealed that hair bundles were retained on a number of cells positive for activated caspase-3, demonstrating that the hair cell death can already be underway prior to any obvious damage to stereocilia. No labeling for activated caspase-3 was found in areas of complete OHC loss, nor in undamaged control tissue (not shown).
In TEM of thin sections, regions of ongoing OHC death could be identified in the middle turn of the cochlea at 24 h and in the apical turn at 48 h posttreatment. In such regions, many OHC displayed morphological characteristics of apoptosis: nuclei with marginated and condensed chromatin, condensed cell cytoplasm, and distorted cell shape (Fig. 2D,E). OHC showing the morphological features of necrosis were not found in thin sections, but scattered debris apparently from ruptured OHC was free within the extracellular spaces of the organ of Corti at the locations of missing OHC (Fig. 2E,F). Often, such debris enclosed what appeared to be condensed chromatin – similar to an apoptotic nucleus – (Fig. 2F) at levels in the epithelium expected of an OHC nucleus. Confocal light microscopy of whole mount samples immunohistochemically labeled for prestin confirmed that such debris was derived from OHC. Within the spaces of the organ of Corti, irregular material, positively labeled for prestin, surrounded dense DAPI-labeled bodies indicative of condensed nuclear chromatin at the position of OHC nuclei (Fig. 2G). In the regions of the organ of Corti just basal to the area of ongoing hair cell degeneration where hair cell loss was complete, there was no debris, suggesting such cell fragments were cleared rapidly.
IHC death and survival
At least some IHC appeared to fragment just below the level of the cuticular plate with the apical fragment released into the endolymphatic space. SEM revealed globular structures, reminiscent of cellular material, at the apical surface at the sites of IHC (Fig. 4J). Apical fragments of IHC, consisting of stereocilia, the cuticular plate, and some cytoplasmic material containing apparently intact mitochondria, were sometimes found lying atop the reticular lamina above the locations of IHC, in the endolymphatic space below the tectorial membrane (Fig. 4K).
FM1-43 labeling of hair cells
One reason for the persistence of IHC when OHC die might be that they do not take up aminoglycoside as readily as OHC. To examine this issue, we investigated the uptake of the fluorescent lipophilic dye FM1-43 into hair cells in the mature organ of Corti. FM1-43 is of similar size to aminoglycoside (MW FM1-43 452, kanamycin 484) and, like aminoglycosides, FM1-43 is a cation. In sensory epithelia of the inner ear, FM1-43 preferentially labels hair cells. It has been suggested that the dye enters hair cells via the transduction channel at the tip of the stereocilia (Gale et al. 2001; Meyers et al. 2003), and because aminoglycosides can bind to the transduction channel and FM1-43 can inhibit the aminoglycoside-induced injury to hair cells in organotypic culture of the early postnatal organ of Corti, it has been argued that FM1-43 and aminoglycosides enter hair cells by the same route (Gale et al. 2001). Consequently, FM1-43 may act as a nontoxic “mimic” for aminoglycosides.
However, it is possible that the isolation of the cochlea, opening it, and the exposure to in vitro conditions lead to abnormal, sustained opening of the transduction channels in both OHC and IHC and/or the dye is not efficiently washed away and uptake occurs through several routes, including endocyototic activity (although the use of low temperatures for postexposure washing in buffer maintained on ice was included to restrict endocytotic activity). Thus, the entry of FM1-43 into hair cells in vivo and the effects of coadministration of bumetanide upon uptake were examined. Two hours after administration either with or without coadministration of bumetanide, no dye uptake was evident in the organ of Corti. At 6 h after systemic injection of FM1-43 in conjunction with bumetanide, both IHC and OHC in the lower apical coil were labeled (Fig. 5B). At 24 h, IHC and OHC were both labeled, IHC seemingly more intensely than OHC (Fig. 5C). In the cochleae of mice that received only FM1-43, but not bumetanide, there was very little labeling of the hair cells at 6 h, and the intensity of labeling at 24 h (Fig. 5D) appeared less than in the cochleae of animals coadministered the diuretic, but again, both IHC and OHC were labeled. In utricular maculae from mice coadministered FM1-43 and bumetanide, the intensity of FM1-43 labeling in hair cells was markedly lower than that in organs of Corti of the same set of animals (Fig. 5E) and very little different from labeling of utricular hair cells in mice that received only FM1-43. However, dye labeling was present and quite intense in the capillaries underlying the utricular macula, demonstrating that FM1-43 had reached the vestibular organs (Fig. 5E).
Supporting cell rearrangement following OHC loss
There was considerable structural reorganization amongst the supporting cells during and following lesion closure. Normally, the phalangeal processes of Deiters’ cells rise at an angle from the cell body region, enclosing one OHC body to contact the apices of OHC at least one OHC distant crossing over another OHC body on the way (Fig. 6D). In the repaired organ of Corti, the Deiters’ cell phalangeal processes rose straight up from the cell body without angulation, suggesting movements of the heads of the supporting cells at the level of the reticular lamina (Fig. 6E,F). Some Deiters’ cells were rounded as the reorganization proceeded and the cell body enclosing the nucleus was at a more apical (luminal) position than normal (Fig. 6F,G); although, whether these cells lost contact with the basilar membrane was not confirmed. Despite these morphological changes, Deiters’ cell bodies retained close contact with their neighbors (Fig. 6G). The repaired epithelium was narrower, with the outermost edge of the epithelium closer to the pillar cells than in undamaged tissue. The epithelial surface was buckled so that an inward furrow was created along the length of the epithelial surface with the Hensen’s closely approaching the pillar cells (Fig. 6H,I). However, although there was rearrangement of Deiters’ cells, they retained most of their obvious structural specializations, including prominent, organized microtubule bundles in the cell body region and at the base of the cell in contact with the basilar membrane (Fig. 6G). Other than the expansion of the head of the outer pillar cell to close lesions where OHC in the first row were lost (Fig. 6A,B), and retraction of the head of some inner pillar cells (Figs. 3C and 6I), there was little alteration of the phalangeal processes or cell bodies of the pillar cells. The tunnel of Corti remained widely open (Fig. 3B,D), flanked by the phalangeal processes both of the outer and the inner pillar cells, which remained erect, supported by their bundles of microtubules, which remained undisturbed (Fig. 6J). Overall, there was little structural evidence of any significant de- or redifferentiation of supporting cells even after quite prolonged periods following loss of OHC.
Despite considerable reorganization of the sensory epithelium in the OHC region, in many cases, IHC persisted (Figs. 3C and 6H). They remained even when there was buckling of the reticular lamina caused by the inward movement of the Hensen’s cells (Fig. 6H). Conversely, there was IHC loss when pillar cells and the arch of Corti were intact (Figs. 3B and 6J). The death of IHC, when it occurred, therefore, did not appear to be directly related to the reorganization of the epithelium occasioned by death of OHC and the subsequent structural rearrangements amongst the supporting cells.
Effects on the SV
In contrast, in animals in which there was hair cell loss taken at 7 days posttreatment and at subsequent time points, there was a significant decrease in strial thickness (Figs. 7D,E; 8). One-way ANOVA statistics revealed a significant decrease for both apical and basal coils at 2 weeks posttreatment in comparison with controls and a further significant decrease between 4 weeks posttreatment and 8 weeks and later times. This would indicate a progressive reduction in strial thickness continuing for some time concomitant with the reorganization of the sensory epithelium following hair cell loss. In some animals at the later time points, (2–3 months) the strial thickness was only 10–12 μm and the basal cell layer was still intact, intermediate cells were difficult to distinguish, and marginal cells were severely reduced (Fig. 7E).
Amikacin or gentamicin with bumetanide
Mice tolerated amikacin as equally well as kanamycin. All animals survived injections with doses of amikacin at 1 mg/g (n = 6). When amikacin was administered with bumetanide, complete loss of OHC was evident, but IHC survived for at least 14 days (n = 3). As others have noted (Wu et al. 2001), gentamicin was not well tolerated. Single injections of doses greater than 0.3 mg/g caused rapid death of the animals (n = 6). Gentamicin at 0.25 mg/g, when given in combination with bumetanide, had no damaging effect on the cochlea (n = 3). However, some animals survived injection of gentamicin at 0.3 mg/g followed by bumetanide. In these animals, complete loss of all OHC but persistence of IHC was also evident at 7 (n = 3) and 14 days posttreatment (n = 2). These observations indicate that the relative resistance of IHC following kanamycin–bumetanide treatment is not drug-specific.
Age effects on OHC loss
In animals at 18–21 days of age, the organ of Corti is structurally mature and the animals can hear. Animals of this age were used partly to keep injection volumes as small as possible, partly because it has been suggested that animals of this age are more sensitive to the aminoglycoside–diuretic combination than older animals (Prieve and Yanz 1984). To test the age-dependence of hair cell loss, animals aged 25, 30, and 35 days (n = 3 in each case) were treated and their cochleae examined 7 days after treatment. Complete loss of OHC from base to apex was observed in the 25- and 29-day-old animals, but in two out of the three animals at 35 days, OHC remained in the apical coil, although there was still scattered loss in this region too.
The kanamycin–bumetanide protocol used here provides a robust method to induce consistently extensive hair cell loss from the mature organ of Corti in mice. The death of OHC occurs rapidly in a defined pattern the same as that found in many other conditions, both of acquired hearing loss and due to genetic defects, over much longer time scales. In spite of the rapid and extensive loss of OHC, supporting cells appear to close the lesions as efficiently as when hair cell death occurs less extensively, and structural reorganization of the supporting cell region of the organ of Corti ensues. In general, the repair process shows features previously reported following chronic hair cell loss regimes in guinea pigs (Forge 1985; Raphael and Altschuler 1991). The reorganization involves considerable movements of the Deiters’ and Hensen’s cells, as well as changes in cell shape and, in some Deiters’ cells, a relocation of the nucleus to a more apical position, though whether any of these cells also lose contact with the underlying extracellular matrix of the basilar membrane could not be confirmed. However, over the time scale examined, supporting cells appeared to retain most of their normal structural specializations with little evidence of any dedifferentiation. Further studies of whether functional specialization of supporting cells is retained following hair cell loss are currently underway. Both in animals and in humans, at prolonged periods following loss of all hair cells, continuing remodeling of the remaining supporting elements of the organ of Corti ultimately results in its replacement by a thin, nonspecialized epithelium covering the basilar membrane. Death of supporting cells may occur during this progression (Ladrech et al. 2007). The movement of the Hensen’s cells towards the pillar cells, that was seen in the present work, and which would lead to Deiters’ cells becoming covered over lumenally and enclosed within the epithelium, may herald the initiation of these further steps in the epithelial remodeling. However, neither obvious death of supporting cells, nor the complete replacement of the organ of Corti was seen over the period of up to 3 months after treatment that was examined. Studies of the cochleae of mice taken after longer periods following the treatment are currently in progress. Nevertheless, the results presented here suggest that the protocol used does potentially provide a means to examine the mechanisms of hair cell death and the response of supporting cells in the cochleae of mature mice in vivo, which can be applied in transgenic animals to explore the molecular basis of repair and recovery processes.
Loop diuretics such as bumetanide are not thought to act directly on hair cells nor to have any long-term effects in the cochlea, and no such effects of bumetanide on its own were found here. Single doses of kanamycin on their own also caused no obvious damage to the organ of Corti or SV in either the short or long term. However, loop diuretics are known to significantly enhance uptake of aminoglycosides into the endolymphatic compartment of the cochlea (Tran Ba Huy et al. 1981), whereas perilymphatic levels of aminoglycoside are not increased by coadministration of a loop diuretic (Russell et al. 1979). If a major route of aminoglycoside entry to the hair cell is via the transduction channels at the tips of stereocilia (Gale et al. 2001; Marcotti et al. 2005; Waguespack and Ricci 2005), then facilitation of uptake to the endolymph would facilitate access of aminoglycoside to its site of hair cell entry. The results from the studies of FM1-43 support this contention. FM1-43 is similar in size and charge to aminoglycoside. The diuretic significantly enhanced its uptake into cochlear hair cells over that which occurs with administration of dye alone. Although FM1-43 may enter IHC through endocytotic activity at the basal pole (Griesinger et al. 2002), the major site of entry is thought to be through the transduction channels (Gale et al. 2001; Meyers et al. 2003). Thus, the diuretic can facilitate access of the dye to the endolymphatic compartment of the cochlea and the apical poles of the hair cells. Furthermore, while dye entry into cochlear hair cells was enhanced, entry into vestibular hair cells was not, a pattern of dye distribution that mirrors the pattern of hair cell loss. The bumetanide–kanamycin combination produced extensive death of cochlear hair cells, but the vestibular organs were completely unaffected, a differential sensitivity to a diuretic–aminoglycoside combination also found in chinchillas (McFadden et al. 2002). Thus, the dye appears to be a tracer for the distribution of the damaging agent. It seems likely, therefore, that the death of cochlear hair cells following kanamycin–bumetanide treatment is a result of the action of the aminoglycoside upon them, whereas the diuretic acts to promote the very rapid entry of a high concentration of the aminoglycoside into the endolymphatic compartment. If the results of FM1-43 uptake studies are a reasonable measure of aminoglycoside entry, then the drug may be at high levels in hair cells by 6 h posttreatment, a time compatible with the loss of OHC in most of the basal coil by 18 h.
The morphology of nuclei labeled with DAPI or propidium iodide and seen in thin sections confirmed that OHC were dying via programmed cell death. The presence of TUNEL-positive nuclei and the identification of activated caspase-3 suggests that the “classical” caspase-dependent apoptotic pathway was triggered, at least in OHC, in response to the ototoxic damage. This supports a previous observation of activation of caspase-3 during OHC death in vivo following a chronic amikacin treatment regime in juvenile rats (Ladrech et al. 2004). In contrast, in a previous study of OHC loss following chronic treatment of mature mice with kanamycin alone over a 14-day period, neither TUNEL- nor activated caspase-3-positive OHC could be detected during the period of several days following treatment over which OHC died (Jiang et al. 2006). The evidence presented there suggested that, following aminoglycoside-induced injury to the mature organ of Corti in vivo, OHC die by caspase-independent apoptotic pathways. One difference between that work and the present one (in addition to the exposure of animals to bumetanide) is in the different timing of the onset and progression of injury; that is, between a chronic condition and acute hair cell loss. During the rapidly progressive hair cell death that is initiated following noise trauma in the mature organ of Corti in vivo, both TUNEL-positive nuclei and caspase-3 activation have been identified (Hu et al. 2002; Nicotera et al. 2003; Hu et al. 2006; Jiang et al. 2006). Caspase activation appears also to be involved in the acute aminoglycoside-induced apoptotic death of hair cells in explant cultures of the avian basilar papilla (Cheng et al. 2003) and the utricular maculae of birds (Matsui et al. 2002, 2004) and of mammals (Forge and Li 2000; Cunningham et al. 2002). The basis of a difference in hair cell death pathways between chronic and acute aminoglycoside exposure conditions in vivo is, however, difficult to explain. Differences in routes of drug entry and, thus, access to different cellular compartments, in rate of accumulation of aminoglycoside inside the cell, in the level and nature of damaging free radicals that are released, or some combination of those might be involved.
However, the present results do not rule out the existence of caspase-independent routes of hair cell death under the conditions used. As Ladrech et al. (2004) also found, not all OHC that showed apoptotic nuclei labeled for activated caspase-3 and the number of such positively labeled cells was relatively small. This may indicate that, whereas some cells are triggered to die via the classical apoptotic route, other cells are subjected to alternative signals leading to an apoptotic death by caspase-independent pathways (Jiang et al. 2006). Alternatively, it may be that only a small number of cells label for activated caspase-3 either because the activated enzyme is expressed only transiently or rupture of apoptotic OHC through a secondary necrosis (discussed below) occurs soon after the activation of caspase-3 such that the enzyme, along with other soluble cytoplasmic components, are released into, and become dissipated within, the fluid spaces of the organ of Corti.
Necrosis amongst OHC was almost completely undetectable. The presence of cellular debris closely associated with condensed apoptotic-like nuclei in regions of ongoing OHC death, observed both in sections and whole mounts, is, thus, most likely due to OHC entering the apoptotic pathway but failing to complete it. An as-yet undocumented death pathway may be involved, but it would be more reasonable to assume that apoptosis was initiated and then, before total shrinkage of the cell had occurred, the plasma membrane burst to release cell contents within the epithelium. In other systems it has been found that cells activating an apoptotic program may undergo “secondary necrosis” and rupture, especially under conditions in which phagocytosis of the apoptotic cell is delayed (Kelly et al. 1999; Wiegand et al. 2001). In the organ of Corti, supporting cells appear to have a role in clearing the dying hair cells (Abrashkin et al. 2006), and in mammalian vestibular organs, supporting cells phagocytose the intact apoptotic bodies of hair cells (Li and Forge 1995; Li et al. 1995; Forge and Li 2000). However, the specialized architecture of the organ of Corti may impede the ability of Deiters’ cells to efficiently phagocytose the apoptotic bodies of the hair cells, with the consequence that secondary necrosis ensues.
IHC death and survival
IHC death, when it occurred, always succeeded loss of all OHC, and IHC often persisted for prolonged periods after all OHC had disappeared from the entire length of the organ of Corti. This suggests a pronounced differential sensitivity to damage between OHC and IHC. In other mammals, including humans (Wright et al. 1987), IHC loss is delayed, and less extensive, relative to loss of OHC, but it is usually found that IHC loss soon follows significant OHC loss and is initiated while OHC not far from the site of IHC death in the same cochlea are still present. The marked difference in damage sensitivity between OHC and IHC that was observed was not a kanamycin-specific phenomenon; the same pattern of hair cell loss was observed when either amikacin or gentamicin was administered instead of kanamycin. The continued presence of IHC when all OHC have been lost has also been observed in mice after chronic kanamycin treatment (Forge et al., unpublished manuscript), suggesting that the differential sensitivity between OHC and IHC is not related to treatment conditions and how quickly OHC die. Prolonged survival of IHC after extensive loss of OHC is also evident in mice with certain genetic defects that lead to hair cell loss. For example, in mice lacking the Kcc4 cotransporter, IHC persist when all OHC are lost and may survive for several months (Boettger et al. 2002), and in Barhl1-deficient mice, while OHC are completely lost by postnatal day 59, IHC may still be present at 6 months (Li et al. 2002). These observations suggest that, in mice, IHC maybe particularly, and unusually, resistant to damage. This may have implications for the use of mice as models for human deafness. Nonetheless, the clear temporal separation between death of OHC from death of IHC that is exposed by the protocol described here provides opportunities to examine the factors that induce death of IHC and of possible intervention strategies to prevent it.
An aminoglycoside can persist in inner ear fluids, both perilymph and endolymph, for a long time after it has been cleared from serum (Harpur and Gonda 1982; Tran Ba Huy et al. 1986). The delay in IHC death commonly observed following aminoglycoside exposure could be attributable to persistence of drug in cochlear fluids leading to continuing uptake into IHC over a prolonged period until a critical level necessary to initiate damage is reached. However, in the present study, the single doses of drugs used were sufficient to cause rapid death of apical coil OHC. In other species, OHC in the apical coil are relatively less vulnerable to damage than those in the basal coil, and they may persist even when basal coil IHC have been lost. The results of the present study thus suggest a significant resistance of IHC to damage.
A second reason proposed for the relative resistance of IHC in comparison with OHC is differences in the extent of uptake of aminoglycosides between OHC and IHC. As pointed out above, several pieces of evidence suggest aminoglycosides can enter hair cells via the transduction channel (Gale et al. 2001; Meyers et al. 2003; Marcotti et al. 2005; Waguespack and Ricci 2005). The probability of the open state of the transduction channel is greatest for OHC in the basal coil and least for IHC (Gale et al. 2001). Thus, aminoglycosides may enter basal coil OHC most readily and IHC least. However, the experiments exploring the uptake of FM1-43 demonstrated that the dye entered IHC at least as readily as OHC both in vitro and in vivo in the mature organ of Corti, a finding for the in vivo condition in agreement with that of Meyers et al. (2003). This might suggest that differential uptake of aminoglycoside between OHC and IHC cannot account for the prolonged persistence of IHC in the absence of all OHC. It is important to stress that the experiments were not designed to test whether FM1-43 entered hair cells via the transduction channels or by endocytotic activity, although in the in vitro experiments the latter pathway would be restricted by the short (10 s) exposure of the cells to the dye, and by immediate transfer to cold buffer. Rather, the experiments tested merely whether there was differential uptake of FM1-43 between OHC and IHC. Nevertheless, if FM1-43 is a legitimate model of aminoglycoside uptake, then differential resistance between IHC and OHC in the kanamycin–bumetanide-treated mice cannot be explained by differential uptake of the drug. Furthermore, if entry of FM1-43 into IHC indicates that aminoglycoside can enter readily, then the survival of IHC for prolonged periods would imply that IHC have an inherent resistance to damage.
In organotypic cultures of explants of very early postnatal organ of Corti taken from animals at P1 or P2, direct exposure to gentamicin causes loss of IHC at least as early, if not preceding, initial loss of OHC (Camp et al., unpublished manuscript). However, in explants taken from slightly older animals, IHC appear relatively more resistant to aminoglycoside-induced death (Richardson et al. 1997). This might suggest that IHC develop resistance as they mature. Investigation of the molecular characteristics of very early postnatal IHC in comparison with those of older animals may provide clues as to particular survival factors expressed by IHC that underlie their resistance to ototoxic damage. Moreover, this present model in which death of IHC is significantly delayed with respect to that of OHC offers opportunities to explore factors underlying hair cell survival in vivo in the mature organ of Corti.
Also, if our interpretation is correct, then the death of IHC when it occurs may not be directly related to the toxic effects of the drugs but be a secondary phenomenon triggered by factors other than and different from those that initiate OHC death. This may have implications for therapeutic interventions aimed at preventing hair cell loss. Several modes of cell death may be at play during loss of IHC. Apoptotic death of IHC has been demonstrated in juvenile rats treated chronically with amikacin (Lenoir et al. 1999). Both the occurrence of TUNEL-positive IHC nuclei and nuclear morphology in thin sections as observed in the present study confirm in mice that apoptosis is a mode of IHC death following ototoxin-induced damage to the organ of Corti. However, there were also a few IHC that appeared to be necrotic. In addition, there were cells that showed a number of features suggesting they were involved in degeneration of their own cellular material: internalization of the stereocilia and/or the presence of cytoplasmic material and cell organelles enclosed within vacuoles, some of which were double-membraned, a feature described as characteristic of autophagy (Eskelinen 2005; Reggiori and Klionsky 2005).
Autophagy is a mechanism for turnover and recycling of cell components through the lysosomes. It is meant to promote cell survival and protection from damage and is often triggered in response to conditions of stress, including starvation (Debnath et al. 2005; Reggiori and Klionsky 2005). However, autophagy may also be a programmed cell death pathway, which is sometimes called type II cell death. Accumulation of autophagic vesicles in cells is seen in a number of neurodegenerative diseases (Cuervo 2004; Lockshin and Zakeri 2004; Tsujimoto and Shimizu 2005). Autophagy may also be functionally linked to apoptosis: cells initiating autophagy may switch to apoptosis or vice versa (Cuervo 2004; Yousefi et al. 2006). While morphological features similar to autophagy-related cell death were seen in IHC in the present study, unfortunately, there are few specific markers that can be used for more objective immunohistochemical detection of autophagy in mammalian cells. Ultrastructural characteristics determined by electron microscopy are currently the usual means for its identification (Mizushima 2004; Martinet et al. 2006). Consequently, the interpretation that IHC may undergo autophagic degradation must be made cautiously.
Effects on the SV
The kanamycin–bumetanide treatment protocol not only caused extensive hair cell loss, but it also resulted in a significant thinning of the stria that was delayed in onset relative to OHC loss and progressively increased with time. The predominant site of injury appeared to be the marginal cells. The observed reduction in the basal infoldings of most marginal cells, and the apparent apoptotic death of some of them, appear to be characteristics of strial pathology following chronic aminoglycoside treatment (Forge et al. 1987), after noise trauma (Hirose and Liberman 2003) and with aging (Spicer and Schulte 2005). At a more detailed level, some of the abnormalities in marginal cells in the early stages of the progressive atrophy also resemble those described in the stria of aging gerbils (Spicer and Schulte 2005). That work reported stacked parallel clusters of thin processes that do not enclose mitochondria, similar to those identified in this study, as well as “thread-like structures” and “minivesicles” inside marginal cells, reminiscent of what has been defined here as microtubule-like filaments. At later stages of degeneration, there were aggregations of electron dense cellular inclusions, very similar to features in the stria of the aged mice, and which have been observed in the stria of aged gerbils and of noise-damaged mice (Hirose and Liberman 2003; Spicer and Schulte 2005). The similarities in the effects upon the stria across damage paradigms suggest common pathological events at the tissue and cellular level, although there may be differences in the factors that initiate those events. In the present work, damage to the stria was delayed relative to effects on the organ of Corti, and the thinning of the stria first became significant between 1 and 2 weeks posttreatment, coincident with the time of IHC loss. Inspection of the organ of Corti and SV in individual cochleae at the different time points also indicated that, in those cochleae where IHC persisted, the decrease of strial thickness was less than in those at the same posttreatment time where IHC were lost. It may be therefore that the initiation of damage in the stria is related to and follows from changes in ion homeostasis and physiological activity associated with the loss of hair cells. However, strial atrophy in the aging gerbil model appears to be independent of hair cell loss (Schulte and Schmiedt 1992), and in the noise-damaged mouse, in the basal cochlear coil where hair cell loss occurs, the stria appears unaffected (Hirose and Liberman 2003). Thus, effects on the stria may represent a separate damaging event, possibly unrelated to effects in the organ of Corti. Nevertheless, the present protocol may provide a means through which the triggering and progression of strial damage common to the different injuring agents, and of possible interventional strategies, can be examined at the cellular and molecular level applying the resources of various appropriate strains of mice.
A kanamycin–ethacrynic acid treatment protocol similar to that used here has been shown to have a comparable effect on the stria in guinea pigs (Hellier et al. 2002). That study found that, despite significant reduction in strial volume, EP is often maintained at near normal levels for prolonged periods after loss of hair cells. Likewise, EP is not affected significantly even after several weeks during the progressive strial atrophy that follows chronic, repeated aminoglycoside treatment, noise trauma and with aging (Komune and Snow 1982; Schulte and Schmiedt 1992; Hirose and Liberman 2003). It seems reasonable to assume, therefore, that, in the cochleae of mice with atrophying stria, EP is likely to be at close to normal levels and may be sufficient to maintain homeostasis in the changed physiological environment when there are no hair cells. However, in aging gerbils, continuing reduction in strial volume eventually leads to loss of EP (Schulte and Schmiedt 1992). In the present work, in some of the animals taken at 8–14 weeks posttreatment, the extent of strial atrophy was so marked that the normal cellular architecture was difficult to discern, and strial thickness was close to one third normal, a level at which it is said maintenance of EP is no longer possible (Schulte and Schmiedt 1992). It may be, therefore, that the progressive atrophy of the stria in these damaged mouse cochleae may continue to the extent that a condition similar to that in aged gerbils is reached.
Findings, such as those reported here, that there maybe significant effects upon the stria and hair cell loss with different damaging agents has, of course, implications for any hair cell regenerative or replacement therapies that may evolve to ameliorate hearing impairment. The replacement hair cells must have an environment appropriate for their survival and proper functioning. Damage to the stria and to lateral wall fibrocytes, which maybe a primary site of injury with aging (Schulte and Schmiedt 1992; Hequembourg and Liberman 2001) and after noise trauma (Wang et al. 2002), are likely to cause changes in cochlear homeostasis that may well result in an environment unsuitable for the survival of the replacement hair cells. Greater understanding of the pathological processes in the nonsensory tissues of the cochlea, of the ways in which the cochlear environment changes when hair cells die, and of how those might be manipulated is required. The procedure presented in this paper may offer opportunities to address these issues in a variety of mouse models.
This work was supported by a project grant from The Royal National Institute for Deaf People (RNID).